Concepedia

The added value of H2 antagonists in premedication regimens during paclitaxel treatment

Juul M. Cox, Leni van Doorn, Ruben Malmberg, Esther Oomen‐de Hoop, Tessa M. Bosch, Patricia M. L. A. van den Bemt, Ingrid Boere, Agnes Jager, Ron H.J. Mathijssen, Roelof W. F. van Leeuwen

British Journal of Cancer · 2021 · 26 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Hypersensitivity reactions from taxol.

R B Weiss, Ross C. Donehower, Peter H. Wiernik et al. · Journal of Clinical Oncology · 1990 · 1.2K citations

, , +9

Phase I clinical and pharmacokinetic study of taxol.

Peter H. Wiernik, Edward L. Schwartz, J Strauman et al. · PubMed · 1987 · 454 citations

, , +14

Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study

János Szebeni, Carl R. Alving, Franco M. Muggia · JNCI Journal of the National Cancer Institute · 1998 · 344 citations

, , +15

Diagnosis and management of drug hypersensitivity reactions

Antonino Romano, Marı́a José Torres, Mariana Castells et al. · Journal of Allergy and Clinical Immunology · 2011 · 198 citations

, , +12

Paclitaxel-Associated Hypersensitivity Reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer Center

Maurie Markman, Alexander Kennedy, Kenneth Webster et al. · Journal of Clinical Oncology · 2000 · 193 citations

, , +11